Maria Secrier
Maria Secrier
Lecturer in Computational Biology, UCL Genetics Institute, University College London
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Using graph theory to analyze biological networks
GA Pavlopoulos, M Secrier, CN Moschopoulos, TG Soldatos, S Kossida, ...
BioData mining 4 (1), 1-27, 2011
6202011
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis
JMJ Weaver, CS Ross-Innes, N Shannon, AG Lynch, T Forshew, ...
Nature genetics 46 (8), 837-843, 2014
2982014
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance
M Secrier, X Li, N De Silva, MD Eldridge, G Contino, J Bornschein, ...
Nature genetics 48 (10), 1131-1141, 2016
2432016
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
CS Ross-Innes, J Becq, A Warren, RK Cheetham, H Northen, ...
Nature genetics 47 (9), 1038-1046, 2015
2182015
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics
X Li, HE Francies, M Secrier, J Perner, A Miremadi, N Galeano-Dalmau, ...
Nature communications 9 (1), 1-13, 2018
1192018
The ABC of reverse engineering biological signalling systems
M Secrier, T Toni, MPH Stumpf
Molecular BioSystems 5 (12), 1925-1935, 2009
572009
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
F Noble, MA Lloyd, R Turkington, E Griffiths, M O'Donovan, JR O'Neill, ...
Journal of British Surgery 104 (13), 1816-1828, 2017
562017
Visualizing time-related data in biology, a review
M Secrier, R Schneider
Briefings in bioinformatics 15 (5), 771-782, 2014
492014
Arena3D: visualizing time-driven phenotypic differences in biological systems
M Secrier, GA Pavlopoulos, J Aerts, R Schneider
BMC bioinformatics 13 (1), 1-11, 2012
492012
Identification of prognostic phenotypes of esophageal adenocarcinoma in 2 independent cohorts
T Sawas, S Killcoyne, PG Iyer, KK Wang, TC Smyrk, JB Kisiel, Y Qin, ...
Gastroenterology 155 (6), 1720-1728. e4, 2018
432018
Molecular landscape of esophageal cancer: implications for early detection and personalized therapy
FR Talukdar, M di Pietro, M Secrier, M Moehler, K Goepfert, SSC Lima, ...
Annals of the New York Academy of Sciences 1434 (1), 342-359, 2018
382018
Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma
A Noorani, X Li, M Goddard, J Crawte, LB Alexandrov, M Secrier, ...
Nature genetics 52 (1), 74-83, 2020
282020
Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with …
M Secrier, X Li, N de Silva, MD Eldridge, G Contino, J Bornschein, ...
Nat Genet 48 (10), 1131-41, 2016
262016
Molecular effects of Lapatinib in the treatment of HER2 overexpressing oesophago-gastric adenocarcinoma
N De Silva, L Schulz, A Paterson, W Qain, M Secrier, E Godfrey, H Cheow, ...
British journal of cancer 113 (9), 1305-1312, 2015
262015
How neurons migrate: a dynamic in-silico model of neuronal migration in the developing cortex
Y Setty, CC Chen, M Secrier, N Skoblov, D Kalamatianos, S Emmott
BMC systems biology 5 (1), 1-13, 2011
252011
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre-and post-chemotherapy
A Noorani, J Bornschein, AG Lynch, M Secrier, A Achilleos, M Eldridge, ...
Genome research 27 (6), 902-912, 2017
232017
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
M Prudencio, J Humphrey, S Pickles, AL Brown, SE Hill, JM Kachergus, ...
The Journal of clinical investigation 130 (11), 2020
212020
Identification of subtypes of Barrett’s esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data
SG Jammula, AC Katz-Summercorn, X Li, C Linossi, E Smyth, S Killcoyne, ...
Gastroenterology 158 (6), 1682-1697. e1, 2020
212020
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
E Garcia, A Hayden, C Birts, E Britton, A Cowie, K Pickard, M Mellone, ...
Scientific reports 6 (1), 1-17, 2016
212016
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
RC Turkington, LA Knight, JK Blayney, M Secrier, R Douglas, EE Parkes, ...
Gut 68 (11), 1918-1927, 2019
182019
The system can't perform the operation now. Try again later.
Articles 1–20